statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	403
SG - Singapore	142
CN - Cina	92
BR - Brasile	86
SE - Svezia	85
VN - Vietnam	31
IT - Italia	30
DE - Germania	28
IN - India	21
FR - Francia	20
IE - Irlanda	20
ID - Indonesia	15
GB - Regno Unito	14
TR - Turchia	13
HK - Hong Kong	8
RU - Federazione Russa	8
FI - Finlandia	7
JP - Giappone	6
CA - Canada	5
BD - Bangladesh	4
EC - Ecuador	4
IQ - Iraq	4
ZA - Sudafrica	4
AT - Austria	3
CH - Svizzera	3
DZ - Algeria	3
PY - Paraguay	3
UA - Ucraina	3
AE - Emirati Arabi Uniti	2
AM - Armenia	2
AR - Argentina	2
AZ - Azerbaigian	2
CO - Colombia	2
PE - Perù	2
PK - Pakistan	2
PS - Palestinian Territory	2
SA - Arabia Saudita	2
UZ - Uzbekistan	2
VE - Venezuela	2
BO - Bolivia	1
BY - Bielorussia	1
CZ - Repubblica Ceca	1
ES - Italia	1
ET - Etiopia	1
HU - Ungheria	1
IL - Israele	1
JO - Giordania	1
KE - Kenya	1
LA - Repubblica Popolare Democratica del Laos	1
LB - Libano	1
LU - Lussemburgo	1
LV - Lettonia	1
MA - Marocco	1
MY - Malesia	1
NL - Olanda	1
NO - Norvegia	1
OM - Oman	1
PA - Panama	1
PL - Polonia	1
RO - Romania	1
RS - Serbia	1
UY - Uruguay	1
Totale	1.110

Nome	#
C-Met/MIR-130b axis as novel mechanism and biomarker for castration resistance state acquisition	141
Blocking the APRIL circuit enhances acute myeloid leukemia cell chemosensitivity	134
C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition	132
The inhibition of the highly expressed mir-221 and mir-222 impairs the growth of prostate carcinoma xenografts in mice	110
The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities	97
MicroRNAs and prostate cancer	93
MicroRNAs and prostate cancer: From preclinical research to translational oncology	92
A microRNA code for prostate cancer metastasis	86
Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer	84
BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial-mesenchymal transition	79
Functional role of microRNAs in prostate cancer and therapeutic Opportunities	75
Totale	1.123

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	7	0	0	0	0	0	2	2	0	0	0	1	2
2021/2022	100	5	8	6	8	10	3	2	15	3	6	17	17
2022/2023	232	29	35	20	17	29	19	4	20	33	14	11	1
2023/2024	112	7	32	1	11	6	2	7	14	1	0	22	9
2024/2025	224	10	4	14	11	11	19	0	14	46	33	41	21
2025/2026	289	75	20	30	75	77	12	0	0	0	0	0	0
Totale													1.123

IRIS UniCatt